Vol 47, No 2 (2013)

open access

Page views 385
Article views/downloads 622
Get Citation

Connect on Social Media

Connect on Social Media

The β-fibrinogen –455G/A gene polymorphism and the risk of ischaemic stroke in a Polish population

Aleksandra Golenia1, Joanna Chrzanowska-Wasko1, Jeremiasz Jagiella1, Marcin Wnuk1, Antoni Ferens1, Aleksandra Klimkowicz-Mrowiec1, Mateusz Adamski1, Irena Ciecko-Michalska2, Agnieszka Słowik1
DOI: 10.5114/ninp.2013.34462
Neurol Neurochir Pol 2013;47(2):152-156.

Abstract

Background and purpose

Ischaemic stroke is considered to be multifactorial and interactions between environmental and genetic factors play an important role. Although vascular risk factors are well known, the genetic ones are still undiscovered. In the present study, we assessed the significance of the β-fibrinogen –455G/A gene polymorphism and the risk of ischaemic stroke in a Polish population.

Material and methods

426 ischaemic stroke patients classified according to stroke aetiologies (small vessel disease, large vessel disease or cardioembolic stroke) and 234 controls were included in the study. The association of the β-fibrinogen genotypes with ischaemic stroke was tested using logistic regression analysis under dominant, recessive or additive models of inheritance.

Results

The allele and genotype distributions of the β-fibrinogen –455G/A gene polymorphism did not differ significantly between patients and controls (patients: G – 75%, GG – 56.6%, GA – 36.8%, AA – 6.6%; controls: G – 73.7%, GG – 57.3%, GA – 32.9%, AA – 9.8%; p > 0.05, χ2). In addition, logistic regression analysis adjusted for the known risk factors, i.e. hypertension, ischaemic heart disease, myocardial infarction, hypercholesterolaemia, diabetes mellitus and smoking, did not show a role of the studied polymorphism in ischaemic stroke.

Conclusions

The β-fibrinogen –455G/A gene polymorphism is not a risk factor for ischaemic stroke in a Polish population.

Article available in PDF format

View PDF Download PDF file